CA-LAMBDATEST
14.5.2024 19:01:37 CEST | Business Wire | Press release
LambdaTest, a leading cloud-based unified testing platform, is excited to announce its integration with BugHerd, the Australian-based website feedback and bug tracking tool. This collaboration is designed to enhance the efficiency of identifying and logging website bug reports during the testing phase.
BugHerd is a popular website bug-tracking tool that aids organizations by enabling them to easily create and collect bug reports, and track feedback. This streamlines communication by allowing clear pinpointing of issues, while also offering task management features to track bug progress and resolution within development teams.
This integration empowers users to effortlessly report bugs discovered during LambdaTest's comprehensive cross-browser testing sessions directly to their BugHerd project. With a single click, users can generate a new BugHerd task complete with essential details, including screenshots, browser, and operating system information, and the ability to assign the task to a specific team member. This eliminates the need for manual data entry and ensures all critical information is captured for efficient bug resolution.
Mayank Bhola, Co-Founder and Head of Product at LambdaTest, commented on the integration saying, "We're thrilled to offer this integration with BugHerd. It aligns perfectly with our mission to make the lives of testers and developers easier. By combining our efforts, we're simplifying the bug tracking process which is often a major bottleneck in web development."
Setting up the BugHerd integration is straightforward—users just need to enter their BugHerd API token in the LambdaTest settings. This simple step will connect their testing workflow directly to BugHerd, enabling them to start logging bugs immediately.
This new feature is designed to be seamless and easy to use, ensuring that even teams without technical expertise can efficiently enhance their web projects. Users can effortlessly manage their testing directly from LambdaTest and see their issues updated in BugHerd without any complications.
"This integration with LambdaTest underscores our commitment to agencies and web developers by allowing them to seamlessly link browser testing with direct feedback, thereby shortening project timelines and enhancing client satisfaction," said Stephen Neville, CEO of BugHerd.
This partnership between BugHerd and LambdaTest represents a significant step forward in making web testing more integrated and efficient, allowing development teams to deliver higher-quality websites faster and with fewer issues.
For more information about BugHerd’s integration with LambdaTest, please visit https://www.lambdatest.com/support/docs/bugherd-integration/
About LambdaTest
LambdaTest is an intelligent and omnichannel enterprise execution environment that helps businesses drastically reduce time to market through Just in Time Test Orchestration (JITTO), ensuring quality releases and accelerated digital transformation. Over 10,000+ enterprise customers and 2+ million users across 130+ countries rely on LambdaTest for their testing needs.
- Browser & App Testing Cloud allows users to run both manual and automated tests of web and mobile apps across 3000+ different browsers, real devices, and operating system environments.
- HyperExecute helps customers run and orchestrate test grids in the cloud for any framework and programming language at blazing-fast speeds to cut down on quality test time, helping developers build software faster.
For more information, please visit: https://lambdatest.com
About BugHerd
BugHerd is an Australian-based software company whose website feedback platform is used all around the world by creative and web development agencies, SaaS companies, education, and online learning organizations.
The company officially launched to the SaaS market in 2011 and was one of the first-ever Australian teams to grace the US-based startup program 500 Startups and the Australian-based Startmate.
BugHerd gained popularity by carving a niche in the Web Developer and Designer software tool market. It solved the difficulty they faced getting contextual website feedback from non-technical folk.
With Stephen Neville at the helm as CEO, the BugHerd team is committed to helping agencies run their website development projects to budget and on time, keeping their clients happy so that they come back for more.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240514577994/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Backed by Investments Exceeding $1 Billion, PCI Pharma Services Announces Major Expansion of US Sterile Fill-Finish and Drug-Device Delivery Combination Capabilities27.4.2026 16:00:00 CEST | Press release
As pharma manufacturers prioritize US supply chain resilience, highlights include high-speed isolator filling lines for prefilled syringes, cartridges and vials, and drug-device combination assembly and packaging. PCI Pharma Services (“PCI”) – a world-leading integrated global contract development and manufacturing organization (CDMO) focused on innovative biologic and small molecule therapies – announced a series of major infrastructure investments that substantially deepen its sterile fill-finish and advanced drug delivery capabilities. As pharma manufacturers and their development partners increasingly prioritize US supply chain resilience, PCI’s latest investments come as part of a broader commitment exceeding $1 billion across the CDMO’s US and European operations, reinforcing its ability to provide seamless support for drug product development and manufacturing, clinical trial supply and drug-device combination assembly from clinical stages through commercial launch – all underpi
Pure Lithium Appoints Renowned Battery Expert Dr. Yuan Gao to Board of Directors27.4.2026 15:53:00 CEST | Press release
Pure Lithium Corporation, a vertically integrated lithium metal battery technology company, is pleased to announce that world-renowned inventor and battery expert Dr. Yuan Gao has joined the company’s Board of Directors. Dr. Gao has been an invaluable member of Pure Lithium’s Scientific Advisory Board since October of 2023. "We are thrilled to have Dr. Gao join our board as we focus on rapidly scaling our technology in the most capital efficient manner possible,” said Pure Lithium Founder, Chairman and CEO Emilie Bodoin. “Dr. Gao is a brilliant scientist who also has deep commercial expertise, a rare combination. He is also unique in the industry because his experience spans the entire battery materials value chain, including all of Pure Lithium’s verticals. His insights over the years have been critical in advancing our technology, and his experience as a director of public companies will strengthen our board.” Dr. Gao commented: “I am thrilled to join the board of Pure Lithium Corpor
Taiho Oncology, Taiho Pharmaceutical and Araris Biotech AG Advance ADC ARC-02 into Phase 1 Clinical Development27.4.2026 15:00:00 CEST | Press release
Phase 1 dose-escalation trial represents the first clinical trial of a product developed using the AraLinQ™ ADC technology and marks Taiho’s expansion into the clinical development of ADCs for oncology Taiho Oncology, Inc., Taiho Pharmaceutical Co., Ltd., and Araris Biotech AG (“Araris”) today announced that the U.S. Food and Drug Administration (FDA) has completed its Investigational New Drug (IND) review period for ARC-02, an antibody-drug conjugate (ADC) being developed for the treatment of non-Hodgkin lymphoma, enabling Taiho Oncology to initiate a Phase 1 dose-escalation clinical trial of ARC-02. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427127507/en/ Taiho Pharmaceutical acquired Araris Biotech in March 2025, expanding Taiho group’s capabilities in biologics and ADC research and development. Araris is a spin-off of the Paul Scherrer Institute and ETH in Switzerland focused on the development of antibody-drug co
Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 202627.4.2026 15:00:00 CEST | Press release
Premier global event to highlight how organizations are bringing data to life to power everything from AI to BI Boomi, the data activation company, today announced Boomi World 2026, its premier annual user conference, taking place May 11 - 14, 2026 in Chicago, IL. The event will bring together customers, partners, and industry leaders from around the world to explore how data activation is transforming the enterprise and accelerating the path to AI-driven outcomes. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427600340/en/ Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 2026 Boomi World 2026 will spotlight data activation — bringing data to life to power AI, analytics, and intelligent automation. Attendees will gain firsthand insights into how the Boomi Enterprise Platform enables businesses to unify data, streamline operations, and innovate faster in an increasingly agentic world.
Axinn Appoints Rachael Philbin as Chief Innovation Officer27.4.2026 15:00:00 CEST | Press release
Appointment Reflects Firm's Vision for the Future of Legal Practice Axinn, Veltrop & Harkrider LLP today announced the appointment of Rachael Philbin as Chief Innovation Officer, reinforcing the firm’s continued investment in advanced solutions and technology for legal services delivery. Philbin joins from Proskauer Rose LLP, where she served as Innovation & Transformation Officer. Based in Axinn's New York office, she will lead the firm’s AI and legal technology initiatives as well as knowledge management efforts, accelerating adoption and integration across its antitrust, intellectual property, and litigation practices. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427277725/en/ Rachael Philbin joins Axinn, Veltrop & Harkrider LLP as Chief Innovation Officer. “As Axinn continues to grow, we are making deliberate investments in the capabilities that enable our lawyers to deliver service and results at the highest level
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom